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Background: Caregivers of dementia patients have significantly higher 
levels of serum IL-6 and CRP compared to non-caregivers, and the 
accumulation of everyday stressors reportedly promotes the induction of 
inflammatory markers. However, few studies have identified factors that 
affect catecholamine levels in caregivers who experience a combination of 
physical and mental stress from caregiving.
Purpose: This study aimed to identify physical factors that impact 
catecholamine levels in caregivers of dementia patients. Methods: 
Participants were elderly caregivers living together with elderly 
Alzheimer’s-type dementia patients. We performed logistic regression 
analysis, with levels of adrenaline, noradrenaline, and dopamine (indicators 
of catecholamine) as dependent variables. Results: Caregiver BMI had a 
significant impact on adrenaline levels (OR: 0.792; 95%CI: 0.654-0.960) 
and noradrenaline levels (OR: 1.210; 95%CI: 1.009-1.451), whereas age 
had a significant impact on dopamine levels (OR: 1.162; 95%CI: 1.019-
1.324). Discussion: While caregiver BMI significantly impacted adrenaline 
and noradrenaline levels, the mechanism underlying these relationships 
is unclear. One possibility is that obesity (BMI) and a rise in sympathetic 
nerve activity contributed to hypertension. Our findings suggest that 
chronic stress in elderly caregivers may potentially impair the dopaminergic 
activation system in the brain. Conclusion: There is a need to identify 
factors which increase BMI in caregivers. Future studies aimed at gaining 
a better understanding of the lifestyle habits of caregivers and intervention 
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1. Introduction
The mortality risk of caregivers has been reported to 
be 63% higher than that of non-caregivers [1]. The chronic 
stress experienced by caregivers of dementia patients is 
thought to cause physiological changes in the body. Levels 
of D-dimer, a marker of fibrin formation and degradation, 
are reported to be significantly higher in caregivers than 
in non-caregivers [2]. Similarly, caregivers of dementia pa-
tients have higher serum IL-6 and CRP levels relative to 
non-caregivers, and the accumulation of everyday stress-
ors promotes an increase in inflammatory markers [3]. 
Patients with probable Alzheimer’s type dementia have 
a median survival period of 11.3 years from onset and 5.7 
years from diagnosis [4]. Caregivers of dementia patients 
are reported to experience a greater level of physical bur-
den and mental distress than caregivers of patients with 
other disorders [5]. One in three caregivers experiences 
depression, with depression occurring more frequently in 
caregivers of dementia patients compared to caregivers of 
patients with other chronic diseases [6].
Aging and chronic stress can have a devastating im-
pact on the vulnerable brain [7]. The various emotions 
resulting from stress are caused by neurotransmitters such 
as noradrenaline and dopamine. Pathways triggered by 
these neurotransmitters have been studied in detail and 
are known to be closely related to emotions [8]. Activation 
of sympathetic nerves results in the secretion of catechol-
amines (adrenaline, noradrenaline, and dopamine), lead-
ing to vasoconstriction, increased heart rate, and increased 
blood pressure, which can result in the onset of circulato-
ry disorders. Moreover, mental stress is known to excite 
sympathetic nerves [9]. Many organs are innervated by au-
tonomic nerves. For instance, autonomic nerves innervate 
endocrine grands and regulate hormone secretion. 
Only a few studies have examined factors which im-
pact catecholamine levels when caregivers of dementia 
patients suffer from a combination of physical and men-
tal stress due to caregiving. Therefore, the present study 
aimed to identify health-related factors which impact cat-
echolamine levels in caregivers of dementia patients.
2. Methods
2.1 Participants
Participants were elderly caregivers living together 
with Alzheimer’s-type dementia patients, and included 
caregivers who had good control of chronic diseases such 
as hypertension, diabetes, and dyslipidemia. Those with 
severe heart diseases and stroke were excluded.
2.2 Research Design
This was a cross-sectional study conducted to analyze 
factors which influence catecholamines in caregivers.
2.3 Caregiver Scales and Assessed Factors
To evaluate catecholamines, we assessed the levels of 
adrenaline, noradrenaline, and dopamine. Adrenaline has 
a heart-stimulating effect and is also involved in sugar and 
fat metabolism, noradrenaline has a hypertensive effect, 
and dopamine (a precursor of noradrenaline) has a specific 
effect on the central nervous system, renal system, circu-
latory system, and digestive system. The higher the levels 
of these catecholamines, the stronger their impact on the 
cardiovascular system.
The Japanese version of the Zarit Burden Interview 
(ZBI) was used to assess caregiver burden [10]. We also as-
sessed BMI by caregivers. 
2.4 Ethical Considerations
This study was approved by the ethics committee of 
Nagoya University Graduate School of Medicine. Par-
ticipants provided informed consent after they received 
a clear explanation that participation in the present study 
was voluntary.
2.5 Statistical Analysis
For logistic regression analysis, dichotomized (high 
or low) levels of adrenaline, noradrenaline, or dopamine 
based on median levels were entered into the models as 
dependent variables. Statistical analyses were performed 
using SPSS25. P<0.05 was considered statistically signifi-
cant.
3. Results
Of the participants, 23 were male and 29 were female. 
Levels of noradrenaline and dopamine were slightly high-
er than reference levels. Median systolic blood pressure 
values were 143.0 and 134.8 for males and females, re-
spectively, with no significant difference between the two 
(P=0.574; Table 1).
Table 2 shows the results of the bivariate correlation 
matrix. Noradrenaline levels were significantly correlated 
with dopamine levels (r=0.456, p<0.05), but no significant 
correlation was observed between adrenaline and nor-
adrenaline levels.
Table 3 shows the results of the bivariate correlation 
matrix for hormone secretion and caregiver factors. 
Adrenaline levels showed a significant negative correla-
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tion with BMI (r=-0.345, P<0.05), while noradrenaline 
levels showed a significant positive correlation with BMI 
(r=0.297, P<0.05). Dopamine levels showed a significant 
positive correlation with age (r=0.354, P<0.05).
Table 4 shows the results of a binomial logistic regres-
sion model with caregiver age, sex, total sense of care bur-
den, BMI, and number of oral medications as independent 
variables. The high and low levels of each hormone were 
entered as dependent variables using the stepwise method. 
Hormone levels were dichotomized based on whether they 
were below or above the respective median level (0, 1) in 
order to extract factors that impact each hormone.
Caregiver BMI was extracted as a factor that signifi-
cantly impacted adrenaline levels (OR: 0.792, 95%CI: 
0.654-0.960) and noradrenaline levels (OR: 1.210, 
95%CI: 1.009-1.451). Age was extracted as a factor 
that significantly impacted dopamine levels (OR: 1.162, 
95%CI: 1.019-1.324). Binomial logistic regression analy-
sis revealed that caregiver BMI significantly impacted.
4. Discussion
The present study identified age and BMI as health-re-
lated factors which impact catecholamine levels in care-
givers of dementia patients.
Noradrenaline levels were found to be significantly 
correlated with dopamine levels. Stress is known to stim-
ulate the hypothalamo-pituitary-adrenal system, as well as 
the sympathoadrenal system [11-13]. Adrenaline is secreted 
into the blood from the adrenal medulla, noradrenaline is 
secreted from sympathetic nerve endings, and cortisol is 
secreted into the blood from the adrenal cortex [14-16]. Both 
noradrenaline and dopamine are secreted from the adrenal 
medulla. Noradrenaline and adrenaline have been report-
ed to inhibit the production of inflammatory cytokines 
by dendritic cells via β receptors [17-18]. However, little 
is known about their other effects. In the present study, 
noradrenaline and dopamine levels were correlated with 
each other, suggesting that both catecholamines may be an 
objective indicator of stress response, which we surmise 
reflects stress from caregiving.
Mental stress tests markedly induce epinephrine re-
lease [19]. Epinephrine (adrenaline) responses are negative-
ly correlated with changes in BMI and waist circumfer-
ence [20]. Moreover, noradrenaline levels at rest have been 
shown to be a positive predictor of BMI [21]. Although 
we identified caregiver BMI as a significant factor which 
impacts adrenaline and noradrenaline levels, how they are 
related mechanistically remains unknown. Some of the 
impairments in plasma glucose-insulin homeostasis noted 
in visceral obesity may be related to an abnormal meta-
bolic response to an adrenaline challenge [22]. According 
to one study, only plasma norepinephrine and BMI were 
significant independent predictors of blood pressure, sug-
gesting that obesity and heightened sympathetic nervous 
system activity contribute to blood pressure elevation [23].
Age was identified as a factor which significantly im-
pacts dopamine levels. Dopamine levels and dopamine 
transporter density have been reported to decrease with 
age[24-25]. However, our results are inconsistent with the 
report that dopamine transporter density declines with 
age. Dopamine levels were heightened in our participants, 
despite them being elderly with a median age of 76 years. 
In fact, we found that dopamine levels tended to increase 
with age, with dopamine and age showing a positive cor-
relation. This suggests that dopamine levels are increased 
in the elderly caregivers of the present study. One reason 
for this observation might be that caregiving activities 
stimulated the brain, which in turn led to the activation of 
dopamine receptors.
Our findings suggest that neurotransmission is likely to 
be highly active in elderly caregivers. Furthermore, given 
that dopaminergic neurons are reportedly more suscepti-
ble to neuroinflammation from chronic stress than other 
types of brain cells[26-27], chronic stress in elderly caregiv-
ers might impair the dopaminergic activation system in 
the brain.
5. Conclusion
The present study identified factors which impact 
catecholamine secretion due to stress in caregivers of 
dementia patients. Specifically, age and BMI were found 
to impact catecholamine levels. In view of this finding, 
identifying factors which contribute to increased BMI 
will be important. Future studies aimed at gaining a bet-
ter understanding of the lifestyle habits of caregivers and 
interventional studies aimed at reducing BMI are needed. 
Furthermore, the small sample size was another limitation 
of this study.  Accordingly, future studies should follow 
and observe these blood biochemical factors in the long 
term.
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Table 1. Participant characteristics
Median IQR (25-75%)
Caregiver Age 76 72-79
Adrenaline (Ref: ≤100) (pg/mL) 39.5 22.3-56
Noradrenaline (Ref: 100-450) (pg/mL) 610 471-718.3




BMI: Body mass Index, SBP: systolic blood pressure, DBP: diastolic 
blood pressure
Table 2. Associations of outcome measures
1 2 3
1. Adrenaline r 1.000
p (two-tailed)
2. Noradrenaline r .137 1.000
p (two-tailed) .333
3. Dopamine r .188 .456* 1.000
p (two-tailed) .183 .001
r: Spearman’s correlation coefficient; p: significance level, *p＜ 0.05
Table 3. Correlations between catecholamines and care-
giver factors
Age SBP BMI
Adrenaline r .099 -.002 -.345*
P .487 .988 .012
Noradrenaline r .002 .030 .297*
P .991 .832 .032
Dopamine r .354* -.066 -.069
P .010 .640 .625
r: Spearman’s correlation coefficient; p: significance level, p＜ 0.1, *p
＜ 0.05, **p＜ 0.01
Table 4. Logistic regression analysis with catecholamines 











Adrenaline BMI -.233 .017 .792 .654 .960




.150 .025 1.162 1.019 1.324
Two groups for each catecholamines based on median 
values were created, as follows: adrenaline (<39.5=0; 
≥39.5=1), noradrenaline (<610=0; ≥610=1), dopamine 
(<21=0; ≥21=1). B: partial regression coefficient, P: level 
of significance, 95%CI: 95% confidence interval, BMI: 
Body Mass Index.
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